business / news / / Finbold
Novo Nordisk (NYSE: NVO) announced a strategic partnership with OpenAI.
Novo Nordisk has partnered with OpenAI to integrate AI across all operational areas by 2026.
KEY POINTS
- Pilot AI programs are already active in Novo Nordisk's research, manufacturing, and commercial teams.
- OpenAI will help upskill Novo Nordisk's workforce to improve AI literacy company-wide.
- Despite the partnership, analysts maintain a cautious 'Hold' consensus on Novo Nordisk stock.
- Novo Nordisk's 2026 outlook predicts a 5% to 13% decline in adjusted sales and operating profit.
COMPANIES
Summarized by Newsio from Finbold. How we summarize →